CARDIOVASCULAR DISEASE (Overview) Toni Mustahsani Aprami, dr., Sp.PD, Sp.JP Department of Cardiology and Vascular Medicine Cardiovascular Subdivision,

Embed Size (px)

Citation preview

  • Slide 1
  • Slide 2
  • CARDIOVASCULAR DISEASE (Overview) Toni Mustahsani Aprami, dr., Sp.PD, Sp.JP Department of Cardiology and Vascular Medicine Cardiovascular Subdivision, Department of Internal Medicine Hasan Sadikin Hospital/Medical School, Padjadjaran University
  • Slide 3
  • Understanding the Cardiovascular System The Heart: A Mighty Machine Four chambers Two upper chambers are called atria Two lower chambers are called ventricles Valves regulate the flow of blood.
  • Slide 4
  • Slide 5
  • Slide 6
  • Conduction System of the Heart 5
  • Slide 7
  • The Heartbeat Is Controlled Each heartbeat is referred to as a cardiac cycle. Takes a total of 0.85 seconds / cycle on the average when at rest..... Thats ~70 X/minute, range 60-80 beats/ minute. Systole - Contraction of heart muscle. Diastole - Relaxation of heart muscle.
  • Slide 8
  • Slide 9
  • Slide 10
  • Slide 11
  • Blood Flow within the Heart
  • Slide 12
  • Blood Vessels 11
  • Slide 13
  • Capillary Bed Anatomy 12
  • Slide 14
  • Capillary Exchange
  • Slide 15
  • Functions of the Cardiovascular System 1.Contractions of the heart generates blood pressure, which moves blood through blood vessels. 2.Blood vessels transport blood, which moves from the heart into arteries, capillaries, and veins, before returning to the heart. 3.Exchanges at the capillaries (smallest vessels) refreshes blood and then tissue fluid (interstitial fluid). 4.The heart and blood vessels regulate blood flow, according to the needs of the body.
  • Slide 16
  • CARDIOVASCULAR DISEASE Congenital Heart Disease (ASD, VSD, PDA, TOF) Rheumatic Heart Disease (MS/MR, AS/AR) Hypertensive Heart Disease Coronary Artery Disease Cardiomyopathies Pericarditis Peripheral Artery Disease Aneurysm and Disectie Aortae Deep Vein Thrombosis Cardiac Tumor
  • Slide 17
  • Coronary Artery Disease 90% Atherosclerosis Process
  • Slide 18
  • Atherosclerosis can, and does, occur in almost any artery in the body. But in the heart its effects can be crucial. The body depends on a strong pumping heart to circulate life-giving blood, and this includes to the heart muscle itself. If the coronary arteries become blocked, the cardiac muscle begins to fail, and so the blood circulation decreases, which includes the circulation to the heart muscle itself. (Thibodeau, 494)
  • Slide 19
  • Atherosclerosis is a disease of large (elastic) and medium sized (muscular) arteries characterized pathologically by smooth muscle proliferation, lipid accumulation, cell necrosis, fibrosis, and calcification. Most commonly involved : Aorta CoronaryCarotidIliacMesentric CoronaryCarotidIliacMesentric
  • Slide 20
  • Slide 21
  • Uncontrollable Sex Hereditary Race Age Controllable High blood pressure High blood cholesterol Smoking Physical activity Obesity Diabetes Stress and anger Predict Risk Diagnostic/Screening test : EST, CRP, Echocardiography, CACS
  • Slide 22
  • Atherogenesis
  • Slide 23
  • Normal Artery Endothelium Internal elastic lamina External elastic lamina Media Intima Adventitia
  • Slide 24
  • Response to Injury
  • Slide 25
  • Endothelial Dysfunction
  • Slide 26
  • Initiation of Fatty Streak
  • Slide 27
  • Fatty Streak
  • Slide 28
  • Fibro-fatty Atheroma
  • Slide 29
  • FIBROUS CAP NECROTIC CENTER MEDIA (smooth muscle cells, macrophages, foam cells, lymphocytes, collagen, elastin, proteoglycans, revascularization) (cells debris, cholesterol crystals, foam cells, calcium)
  • Slide 30
  • Endothelial Dysfunction Foam Cells Fatty Streak Intermediate LesionAtheroma Fibrous Plaque Complicated Lesion/Rupture Endothelial injury nitric oxide endothelin-1 vasodilation Lipid accumulation adhesion molecules (ICAM, VCAM) monocyte adhesion macrophage LDL uptake Inflammation continued macrophage/lipid accumulation leukocyte accumulation cytokines (IL-6,TNFa, IFNg) MMP's CRP (hepatic) oxidized LDL homocysteine smoking aging hyperglycemia hypertension 35-45 yrs45-55 yrs 55-65 yrs >65 yrs The Evolution of Atherosclerosis
  • Slide 31
  • Common Consequences of Atherosclerosis in Vessels
  • Slide 32
  • Altered Vessel Function Vessel change Plaque narrows lumen Wall weakened Thrombosis Breaking loose of plaque Loss of elasticity Consequence Ischemia, turbulence Aneurysms, vessel rupture Narrowing, ischemia, embolization Athero-embolization Increase systolic blood pressure
  • Slide 33
  • Burden and causes of cardiovascular diseases: with an emphasis on Asia
  • Slide 34
  • Chronic diseases and injuries Infectious, maternal, perinatal and nutritional conditions Changing patterns of death Worldwide: 1990-2020 Global Burden of Disease Project, 1996 Millions of deaths
  • Slide 35
  • Leading causes of death Worldwide: 1990-2020 RankCause % RankCause % 1Coronary Artery disease 12.41Coronary Rtery disease 16.3 2Cerebrovascular disease 8.72Cerebrovascular disease 11.2 3Lower respiratory infections 8.53COPD 6.9 4Diarrhoeal diseases 5.84Lower respiratory infections 3.7 5Perinatal conditions 4.45Respiratory tract cancers 3.5 6COPD 3.9 6Road traffic accidents 3.4 7Tuberculosis 2.17Tuberculosis 3.4 8Measles 2.18Stomach cancer 2.3 9Road traffic accidents 1.99HIV 1.8 10Respiratory tract cancers 1.910 Self inflicted injuries 1.8 19902020 Global Burden of Disease Study, 1996
  • Slide 36
  • Reported in 1990 14 million deaths worldwide 5 million in developed countries 9 million in developing countries Predicted for 2020 25 million deaths worldwide 6 million in developed countries 19 million in developing countries Deaths from cardiovascular disease Worldwide: 1990-2020 Global Burden of Disease Study, 1996
  • Slide 37
  • World population change 0 2 4 6 8 10 17001800190020002100 World population (billions) United Nations 1999
  • Slide 38
  • Regional population change Population (billions) 2000 2050 Change Developing world 4.9 7.9 3.0 Developed world 1.0 1.0 0.0 Total 5.9 8.9 3.0 United Nations 1999
  • Slide 39
  • 0 500 1000 1500 2000 2500 3000 3500 Trends in per capita cigarette consumption: 1971-1991 1971 1981 1991 Per capita cigarette consumption High income countries Low & middle income countries China The World Health Report, 1999: Making a Difference
  • Slide 40
  • Tobacco-related death and disability 19902020 Deaths (millions) 3.0 8.4 India 0.1 1.5 China 0.8 2.2 DALYS (%) 2.6 9.0 Global Burden of Disease Project, Lancet 1997
  • Slide 41
  • Trends in overweight/obesity (BMI 25+ kg/m 2)
  • Slide 42
  • 0 50 100 150 200 250 300 350 DevelopedDevelopingWorld Millions 1995 2025 Projected King et al. Diabetes Care 1998; 21:1414-31 0 50 100 150 200 250 300 350 Asia-Pacific Global distribution of diabetes
  • Slide 43
  • Prevalence of smoking in the Asia Pacific APCSC, 2006 Indonesia
  • Slide 44
  • Prevalence of hypertension 140/90mmHg + Indonesia 27 11
  • Slide 45
  • Prevalence of obesity and overweight
  • Slide 46
  • Prevalence of, and predictions for, diabetes
  • Slide 47
  • Summary I Global epidemic of CVD; the leading cause of death and disability About 11 million new cardiovascular deaths each year by 2020 By 2020, 80% of cardiovascular deaths will occur in low and middle income countries About half of these deaths will occur in the Asia-Pacific region
  • Slide 48
  • Summary II Classic CVD risk factors act similarly in different populations These risk factors are already common in many low/middle-income countries, and are often increasing (e.g. Asia)
  • Slide 49